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Sex Differences in Conscious Sedation During Upper
Gastrointestinal Panendoscopic Examination
Yu-Hsuan Yen,1 Tzu-Fu Lin,1 Chen-Jung Lin,1 Yi-Chia Lee,2 Hon-Ping Lau,1 Huei-Ming Yeh1*
Background/Purpose: Sex differences in response to noxious stimuli or analgesia have been demon-
strated. We investigated sex differences in conscious sedation during upper gastrointestinal panendoscopic
examination with regard to drug dose and entropy scores.
Methods: We investigated sex differences in 30 men and 30 women who were undergoing conscious seda-
tion during upper gastrointestinal panendoscopic examination. The drug mixture was prepared as 5 mg
midazolam plus 1 mg alfentanil diluted with normal saline to a volume of 10 mL. An initial injection of
4 mL was followed by an additional 1 mL every 1 minute, until the modified Observer Assessment of
Alertness and Sedation (OAAS) rating scale was ≤ 3 when the panendoscope was inserted. Further injec-
tion was allowed thereafter. Entropy values, including state entropy (SE) and response entropy (RE), were
monitored from baseline to full recovery.
Results: The volume of mixture needed to achieve an OAAS score of ≤ 3 was significantly lower in men
than in women (4.4 ± 0.7 mL vs. 4.8 ± 0.8 mL, p = 0.034). The initial drug demand was not significantly 
influenced by age, body weight, or body height. The RE and SE values at the time of panendoscope insertion
were not significantly different between men and women. The total volume for men was also significantly
lower than that for women (5.7 ± 1.1 mL vs. 6.5 ± 1.4 mL, p < 0.01). The lowest RE and SE values during the
procedure were not significantly different between men and women.
Conclusion: Women need more analgesic agents than men during panendoscopic examination. There
was no significant difference between men and women with regard to anesthetic depth and response to
noxious stimuli, as revealed by similar SE and RE values.
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Men and women are different in many aspects, 
including in the field of analgesia and anesthesia.1
Men and women have different pain thresholds
and responses to noxious stimulation. It has also
been demonstrated that sex differences exist in
pharmacokinetics and pharmacodynamics of anes-
thetic agents.2–5 From a clinical perspective, these
differences are of potential importance and might
affect clinical practice. For patients who are under-
going upper gastrointestinal (UGI) panendoscopic
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examination, conscious sedation is increasingly
used to reduce patient discomfort. Usually, short-
acting medication is used because the panendo-
scopic examination can be accomplished within
30 minutes. However, sex difference has not been
thoroughly investigated in this condition.
In the present study, we enrolled patients who
were undergoing UGI panendoscopic examination
who requested sedation and analgesia. We pros-
pectively evaluated the sex differences in drug 
demand. We also used the entropy scores to mon-
itor the patients’ consciousness level. This is a
newly developed electroencephalography-based
monitoring method to evaluate consciousness.
There are two components in the entropy mea-
surement, namely state entropy (SE) and response
entropy (RE). The SE value represents cortical state,
whereas the RE value represents cortical state plus
electromyographic signals.6 Therefore, the RE score
represents muscle contraction in response to pain
stimulation.7 We analyzed sex differences in SE/RE
scores during the examination, as well as the fac-
tors that influenced drug demand.
Methods
The study protocol was approved by the Institu-
tional Review Board of the National Taiwan
University Hospital, and informed written consent
was obtained from all patients. Sixty consecutive
patients [30 male and 30 female; aged 16–65
years; American Society of Anesthesiologists (ASA)
physical status class 1 or 2] scheduled for UGI
panendoscopy who requested intravenous seda-
tion were enrolled in this study. Those with known
neurological disorders, chronic pain, history of
psychological or analgesia drug use, chronic alco-
hol drinking, old age (> 65 years), and ASA class
≥ 3 were excluded.
No premedication was given before the exam-
ination. All patients were monitored with pulse
oximetry, electrocardiography, and non-invasive
blood pressure measurement. Nasal cannula with
oxygen (5 L/min) was applied. After the skin of the
forehead was carefully wiped with an alcohol swab
and allowed to dry, the EntropyTM self-adhesive
EEG electrode strips (ZipPrep; Aspect Medical
Systems, Newton, MA, USA) were positioned on
the forehead. The electrode was connected to an
Entropy monitor (Datex-Ohmeda S5, Instrumen-
tarium Corp., Helsinki, Finland). SE and RE were
calculated by the spectral entropy plug-in module
of the Datex-Ohmeda monitor.
The analgesic/sedative mixture was prepared as
5 mg midazolam and 1 mg alfentanil diluted with
normal saline to a volume of 10 mL. The patient
was injected intravenously with a 4-mL mixture
as the loading dose. This regimen and dose were
chosen according to past experiences in our hos-
pital and previous survey in the literature.8–10 An
anesthesiologist measured the patient’s response
2 minutes later using the modified Observer As-
sessment of Alertness and Sedation (OAAS) rat-
ing scale (Table 1).10,11 If the patient was still alert
2 minutes after the injection, we injected the
mixture in 1-mL amounts every minute until the
OAAS score was ≤ 3, then the gastroenterologist
Table 1. Modified Observer Assessment of Alertness and Sedation scale and the distribution of scores after
initial injection in men and women
Response and score Women Men
5: Responds readily to name spoken in normal tone 4 2
4: Lethargic response to name spoken in normal tone 15 8
3: Responds only after name is called loudly or repeatedly 7 10
2: Responds only after mild prodding or shaking 3 7
1: Does not respond to mild prodding or shaking 1 3
0: Does not respond to noxious stimuli 0 0
Total number 30 30
The average score was significantly higher in women than in men (3.6 ± 1.0 vs. 3.0 ± 1.1, p = 0.021).
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began to insert the endoscope. An OAAS ≤ 3 was
chosen according to ASA guidelines in sedation.
Entropy scores (including SE and RE) were
recorded from baseline to full recovery of the pa-
tient. Baseline scores, scores at endoscope inser-
tion, scores after insertion, and the lowest scores
(representing the deepest level of anesthesia)
were compared between men and women. During
the whole procedure, the hemodynamic status
and noxious response (e.g. hand movement, gri-
mace, and moaning) were recorded by an inde-
pendent anesthesiologist who was blinded to the
entropy score. Extra doses of the drug mixture
were allowed if necessary, as judged by the above
patient responses. Arterial oxygen saturation
(SaO2) was monitored throughout the procedure.
Severe hypoxia was defined as SaO2 < 90%, which
should be managed by positive pressure ventila-
tion with a face mask, oxygen, and placement of
an artificial airway.
All data were expressed as mean ± standard 
deviation or mean (range). Comparisons of drug
demands and baseline characteristics between men
and women were made using Student’s t test. For
comparison between drug demand and age, body
weight, body height, procedure time, entropy
scores and baseline heart rate, linear regression
was used and R2 and p values were reported. We
also performed power analysis to calculate the
number of patients needed to show a sex differ-
ence. With an α-value of 0.05, a β-value of 0.8 to
detect a difference of 0.5 mL with an estimated
standard deviation of 0.6mL, the total case number
needed was 54 (27 in each group). The statistical
calculations were performed using SPSS version
11.0 (SPSS Inc., Chicago, IL, USA). A p value <0.05
was considered significant.
Results
Table 2 shows the baseline characteristics of the
patients. Body weight and body height were sig-
nificantly greater in men than in women, but the
age and ASA physical status were not significantly
different. The hemodynamic parameters were not
significantly different between men and women,
except for heart rate (Table 3). The time from drug
administration to endoscope withdrawal was not
significantly different between men and women
(11.2 ± 2.2 minutes vs. 11.5 ± 3.0 minutes). There
were one man and one woman who were under-
going gastric biopsy during the procedure. Dur-
ing the UGI panendoscopic examination, no
marked hypoxemia with SaO2 < 90% or hypoten-
sion was noted. No patient suffered from delayed
recovery.
After the initial 4-mL injection, the percentages
of OAAS score ≤ 3 were 67% (20/30) in men and
37% (11/30) in women. The percentage differed
significantly between men and women (p = 0.03
by χ2 test). The distribution of OAAS score after
the first injection is shown in Table 1. The OAAS
score was significantly higher in women than in
men (3.6 ± 1.0 vs. 3.0 ± 1.1, p = 0.021). The vol-
ume of the mixture needed to achieve an OAAS
Table 2. Baseline characteristics of study patients
Men Women p
(n = 30) (n = 30)
Age (yr) 49.6 (34–64) 46.9 (30–65) 0.22
Weight (kg) 80.0 ± 12 57.4 ± 7.8 < 0.05
Height (cm) 171 ± 5.6 161 ± 6.4 < 0.05
ASA class (1/2) 19/11 20/10 0.79
ASA = American Society of Anesthesiologists.
Table 3. Baseline hemodynamic parameters and drug demands during the examination in men and women
Men (n = 30) Women (n = 30) p
Blood pressure (mmHg) 127 ± 18/82 ± 14 125 ± 19/74 ± 13 0.72/0.23
Heart rate (beats/min) 88 ± 18 98 ± 21 < 0.05
O2 saturation (%) 99.7 ± 0.7 99.0 ± 0.2 0.49
Drug demand at insertion (mL) 4.4 ± 0.7 4.8 ± 0.8 < 0.03
Total drug demand (mL) 5.7 ± 1.1 6.5 ± 1.4 < 0.01
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score ≤ 3 in men was 4.4 ± 0.7 mL, which was 
significantly lower than 4.8 ± 0.8 mL in women
(p = 0.034). The total volume in men was 5.7 ±
1.1 mL, which was also significantly lower than
6.2 ± 1.4 mL in women (p= 0.01). The percentages
of further injection during endoscope insertion
were 90% (27/30) in men and 87% (26/30) in
women, and the amount of further injection was
1.3 mL and 1.7 mL, respectively. The body weight
was significantly smaller in women than in men,
therefore, the differences in drug dose were even
larger if expressed as mL/kg body weight. We also
analyzed the influence of other clinical parameters
on drug demand. Table 4 shows that the volume
of mixture needed to achieve an OAAS score ≤ 3
was not significantly influenced by age, body
weight, body height, or procedure time. There was
also no significant correlation between the volume
and the RE and SE scores at the time of endoscope
insertion or at the nadir point. Similar findings
were observed for the total mixture volume, ex-
cept that there was a significant negative correla-
tion between age and total volume. Women and
men had significantly different baseline heart rate;
therefore, we also analyzed the relationship be-
tween baseline heart rate and drug demand in
both groups. With linear regression, R2 was 0.002,
0.064, and 0.019 and p was 0.759, 0.176, and
0.463 for all subjects, men and women respectively.
This indicated that baseline heart rate had no sig-
nificant influence on drug demand.
Table 5 shows the entropy scores during the ex-
amination in both sexes. Baseline entropy scores,
RE and SE, were not significantly different between
men and women, and neither were the entropy
values when patients’ conditions were deemed
appropriate for endoscope insertion (OAAS score
≤ 3), and the values recorded throughout the ex-
amination. The lowest values of RE and SE dur-
ing the examination did not differ significantly
Table 4. Univariate results of the influence of
clinical parameters and entropy scores on
drug demand
Drug demand Total drug 
at insertion demand
p R2 p R2
Sex 0.034* – 0.010* –
Body weight 0.362 0.014 0.212 0.027
Body height 0.118 0.042 0.099 0.046
Age 0.135 0.038 0.013* 0.102
Procedure time 0.457 0.010 0.625 0.004
SE at insertion 0.500 0.008 0.361 0.014
RE at insertion 0.578 0.005 0.447 0.010
Lowest SE 0.514 0.007 0.980 0.000
Lowest RE 0.771 0.001 0.937 0.000
*p < 0.05. R = correlation coefficient; SE = state entropy; RE =
response entropy.
Table 5. Entropy scores during the examination
Men (n = 30) Women (n = 30) p
Entropy baseline
RE 97.9 ± 1.8 97.6 ± 1.5 0.532
SE 88.9 ± 1.2 88.9 ± 1.6 0.854
Entropy (OAAS score ≤ 3)
RE 92.2 ± 2.9 92.5 ± 3.2 0.675
SE 83.6 ± 2.0 84.3 ± 1.9 0.148
Entropy (after endoscope insertion)
RE 93.1 ± 2.8 93.5 ± 3.1 0.608
SE 84.6 ± 2.3 85.2 ± 2.1 0.296
Entropy (lowest value during the examination)
RE 84.5 ± 4.8 86.7 ± 4.0 0.064
SE 77.5 ± 4.5 78.7 ± 2.9 0.225
OAAS = Observer Assessment of Alertness and Sedation scale; RE = response entropy; SE = state entropy.
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between men (RE 84.5 ± 4.8, SE 77.5 ± 4.5) and
women (RE 86.7 ± 4.0, SE 78.7 ± 2.9).
Discussion
In animal or human studies, sex difference in 
response to noxious stimuli or analgesia agents
has been demonstrated, although some con-
troversies still exist. Chia et al have found that
men are more susceptible to postoperative pain
upon movement and require more morphine by
patient-controlled analgesia than women dur-
ing the first three postoperative days.5 However,
to the contrary, we found that women needed 
more analgesic agent than men (4.8 ± 0.8 mL vs.
4.4 ± 0.7 mL) to achieve an optimal sedative sta-
tus during UGI panendoscopic examination. We
also demonstrated that > 60% of women needed
an additional injection after the initial injection
before endoscope insertion. A higher initial dose
can be considered for woman. The contradictory
findings can be attributed to several possible 
reasons. First, the duration of painful stimuli was
different (minutes vs. hours or days), and this
could have influenced the drug demand. Second,
the operative methods and sites of stimulation
were not identical. Finally, the pharmacokinetic
properties might have been different for mor-
phine and midazolam/alfentanil, whose volume
of distribution is higher in women than in men.12
All the above reasons might have contributed to
a lower dose requirement in men.
In our study, we used a mixture of midazolam
(5 mg) and alfentanil (1 mg) as the anesthetic
agents. Analgesic effect was dominant in this reg-
imen because there was a synergistic effect and
the dosage of midazolam was low. This formula
was suitable for titrating the dose without caus-
ing respiratory depression or unfavorable hemo-
dynamic status. We defined an OAAS score ≤ 3 
as the ideal point for inserting the endoscope.
Usually, the gastroenterologist could insert the
endoscope without difficulty. The lowest RE/SE
values during the examination were 84.5 ± 4.8/
77.5 ± 4.5 in men and 86.7 ± 4.0/78.7 ± 2.9 in
women. We found that the optimal SE value
ranged from 70 to 80 during UGI panendoscopic
examination when midazolam and alfentanil
were used.
Bispectral index has been used to evaluate seda-
tive level during surgery or procedural sedation,
with good correlation with clinical observation.13,14
Its usefulness has been confirmed in UGI panen-
doscopic examination.15 However, it has poor
correlation with analgesic effect.11 Entropy has
been newly developed to monitor patients’ con-
sciousness and has been demonstrated to be as
effective as bispectral index in clinical practice.16,17
Furthermore, there are two components in entropy
measurement. SE and RE were both recorded to
represent cortical state and cortical state plus elec-
tromyographic signal, respectively.6 The RE score
therefore represents muscle contraction in response
to noxious stimulation. During noxious stimuli,
there is an increase in RE value alone, or an in-
crease in the difference between SE and RE.7,18
We found that SE and RE scores were not signifi-
cantly different between men and women. This
suggests that there was no significant difference
between men and women with regard to anes-
thetic depth and response to noxious stimuli.
The patients were divided according to sex;
therefore, it was not feasible to blind the study
during patient evaluation. Also, it was not feasi-
ble to randomize the patients. There could have
been bias because this was not a randomized
double-blind study. Serum drug concentrations
were not measured in this study, and we could
not tell whether the difference was due to phar-
macodynamics or pharmacokinetics. Patient satis-
faction score was not measured. An initial 4-mL
of mixture was given as the loading dose. It is
possible that some patients might need < 4 mL to
achieve an OAAS score of ≤ 3. Therefore, the exact
volume might have been overestimated. However,
the overestimation occurred in both groups and
we still demonstrated that women needed more
additional doses than men.
In conclusion, we found that women needed
a higher dose of analgesic agents than men dur-
ing UGI panendoscopic examination, whereas
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there was no significant difference between men
and women with regard to anesthetic depth and
response to noxious stimuli, as revealed by simi-
lar RE and SE values.
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